Using third parties for clinical research support services has numerous practical advantages, but if pharma companies unwittingly cut corners on safety oversight, they could be risking more than they realise – including multiplying their costs. Natalia Vlcek offers some practical tips for covering all bases when partnering externally - Magazine Article - PharmaTimes